Unlocking the Future of the Crohn’s Disease Treatment Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
Analyzing the Growth Rate of the Crohn’s Disease Treatment Market: What’s the Expected CAGR for the Next Decade?
The market for treating Crohn’s disease has witnessed significant expansion in the past few years. The market value is projected to increase from $12.45 billion in 2024 to $13.23 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.2%. Factors contributing to the growth during the historic period include rising disease prevalence, technological advancements in diagnostic procedures, embrace of biological therapies, improved patient awareness and education, and ongoing clinical research and development.
The market for treating Crohn’s disease is predicted to experience significant growth in the upcoming years. The market is expected to surge to $17.67 billion in 2029 with a compound annual growth rate (CAGR) of 7.5%. Factors contributing to this growth include the adoption of personalized medicine techniques, growth of the biologics market, updated treatment guidelines, enhanced healthcare expenditure, and shared research initiatives. Notable trends during the forecast period encompass the use of telemedicine for patient oversight, exploration into immune modulation methods, patient-focused care systems, and the incorporation of digital health solutions.
What Major Innovations Are Driving the Accelerated Growth of the crohn’s disease treatment Market?
The growth of the Crohn’s disease treatment market is anticipated to be fueled by the rising prevalence of inflammatory bowel disorders. These disorders are a collection of chronic ailments that result in inflammation of the gastrointestinal tract, potentially causing inflammation and damage to any part of the digestive system, ranging from the mouth to the anus. Crohn’s disease treatment aids in reducing the inflammation in the intestines, controlling symptoms’ flare-ups, and maintaining remission. The National Center for Biotechnology Information, a government organization based in the US, revealed in September 2023 that both Crohn’s disease and ulcerative colitis prevalence have been on the rise, with inflammatory bowel disease projected at 825 cases per 100,000 individuals in 2023—410 for Crohn’s disease and 414 for ulcerative colitis and IBD-u. Hence, the increasing prevalence of these disorders is driving the expansion of the Crohn’s disease treatment market.
Get Your Free Sample of the Global Crohn’s Disease Treatment Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp
What Are the Leading Organizations Impacting the Crohn’s Disease Treatment Market’s Growth?
Major companies operating in the crohn’s disease treatment market include:
• AbbVie Inc._x000D_
• AstraZeneca plc_x000D_
• Boehringer Ingelheim GmbH_x000D_
• Eli Lilly and Company_x000D_
• Janssen Pharmaceuticals_x000D_
What Are the Most Prominent Trends Driving Change in the Crohn’s Disease Treatment Market?
Leading enterprises in the Crohn’s disease treatment market are developing new medications, such as the biosimilar ustekinumab, and gaining approval for them. This step aims to provide more efficient and readily available treatment alternatives for patients, hence enhancing patient outcomes and quality of life. Biosimilar ustekinumab is essentially a biologic medication closely mirroring the original ustekinumab (a monoclonal antibody) which is used for the treatment of autoimmune conditions. To illustrate, Sandoz International GmbH, a pharmaceutical company based in Switzerland, launched Pyzchiva (ustekinumab) all over Europe in July 2024. This was marked as the first available ustekinumab biosimilar in all strengths, featuring a 130 mg bottle specially designed for Crohn’s disease. This product, indicated for adults and children over the age of six diagnosed with plaque psoriasis, psoriatic arthritis, and Crohn’s disease, bolsters Sandoz’s immunology portfolio while providing accessible and economical treatments for chronic inflammatory diseases.
Get Instant Access to the Global Crohn’s Disease Treatment Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
What Major Market Segments Define the Scope and Growth of the Crohn’s Disease Treatment Market?
The crohn’s disease treatment market covered in this report is segmented –
1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications
Subsegments:
1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics
2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates
3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids
4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine
5) By Other Drug Types: Biologics, Small Molecules, Other Treatments
What Regions Are Leading the Charge in the Crohn’s Disease Treatment Market?
North America was the largest region in the global Crohn’s disease treatment market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the Crohn’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Key Parameters Define the Crohn’s Disease Treatment Market’s Scope?
Crohn’s disease treatment refers to medical intervention and therapies used to manage Crohn’s disease, a chronic pathological condition of the gastrointestinal tract. The treatment aims are to reduce inflammation in the intestines, prevent flare-ups of symptoms, and maintain recovery.
Browse Through More Similar Reports By The Business Research Company:
End Stage Renal Disease (ESRD) Drug Global Market Report 2024
Enteric Disease Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report
Alzheimer’s Disease Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
